RecruitingNot ApplicableNCT07363551
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial
Sponsor
China Medical University Hospital
Enrollment
60 participants
Start Date
Jun 9, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
Eligibility
Min Age: 13 YearsMax Age: 18 Years
Inclusion Criteria1
- Youth with a DSM-5 diagnosis of MDE
Exclusion Criteria2
- Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
- Allergic to omega-3 fatty acids
Interventions
COMBINATION_PRODUCTOmega-3 fatty acids
omega-3 fatty acids (EPA)
DIETARY_SUPPLEMENTPlacebo
soy bean oil
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07363551
Related Trials
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
NCT073894731 location
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
NCT073804121 location
Cognitive Remediation in Forensic Mental Health Care
NCT046106971 location
Studies of Brain and Body Interaction
NCT036722661 location
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
NCT0697357747 locations